Structure-activity analysis of proteins requires the design of several mutant proteins. The expression, purification and accurate comparison of the activity of these different proteins can therefore be very tedious. The use of in vitro-translated proteins is a much faster way to obtain proteins suitable for activity comparison. Moreover, the conditions for in vitro translation are more similar to a eukaryotic environment than to a bacterial system from which proteins are often purified. Nevertheless, the direct comparison of the activity of the in vitro-translated proteins might not reflect a difference in their activity but rather a difference in the amount of protein synthesized in the extract, a problem that has not been addressed so far. We describe a rapid method that permits a semiquantitative comparison of the DNA-binding activity of in vitro-translated proteins. This method is based on the normalization of the DNA-binding activity to the amount of protein synthesized in the assay, permitting a more accurate estimation of the relative affinity for DNA of DNA-binding proteins.
p53 was chosen as an example for a DNA-binding protein. The human p53 gene was cloned at the Nco I/ BamHI sites of a pCITE ® -2a(+) vector (Novagen, Madison, WI, USA). The p53 plasmid was purified with a Wizard ™ Plus Minipreps DNA Purification System (Promega, Madison, WI, USA) and ethanol-precipitated. The plasmid was resuspended in nuclease-free water and its concentration determined by spectrophotometry at 260 nm with a GeneQuant ® II apparatus (Pharmacia Biotech, Uppsala, Sweden). The p53 protein was in vitro-synthesized in rabbit reticulocyte lysate in the presence of 10 µ Ci of 35 S-methionine (Amersham International plc, Little Chalfont, Bucks, England, UK) in a final volume of 25 µ L at 30°C with a Single Tube Protein ™System 2 (Novagen) according to the manufacturer's instructions. After synthesis, a 10-µ L aliquot of the translation mixture was denatured at 95°C for 5 min in Laemmli buffer (3). The solution was loaded onto a 10% sodium dodecyl sulfate (SDS) polyacrylamide gel and run for 1 h at room temperature in a Mini-PROTEAN ® II Electrophoresis System (Bio-Rad, Hercules, CA, USA). The gel was dried under vacuum and the radioactivity of the p53 bands counted with a PhosphorImager ™ (Molecular Dynamics, Sunnyvale, CA, USA). A 6-µ L aliquot of the same translation mixture was incubated in 20 µ L for 1 h at 22°C in the presence of 25 mM HEPES, pH 7.6, 50 mM KCl, 10% glycerol, 5 mM dithiothreitol, 75 µ g/mL poly[dI . dC] . poly[dI . dC], 300 ng of the activating antibody PAb421 (Oncogene Research Products, Cambridge, MA, USA) (2) and 1.5 × 10 -14 mol of double-stranded 32 P oligonucleotide. The sequence of the double -stranded oligonucleotide corresponds to the DNA region recognized by wild-type p53 in the WAF1 promoter (1). The oligonucleotides were phosphorylated with the T4 polynucleotide kinase according to Sambrook 
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Instrument, Meriden, CT, USA). The counter was adjusted so that only the signal emitted between 170 and 1700 keV was recorded. This region corresponds to the 32 P emission and therefore represents the bound oligonucleotide but not the protein radiolabeled with 35 S-methionine. The amount of bound oligonucleotide ( 32 P count obtained from the gel-shift assay) was normalized to the same amount of protein. The amount of protein synthesized in each different experiment is proportional to the 35 S count obtained from SDS polyacrylamide gel electrophoresis (PAGE).
To check the validity of the method, different colonies obtained from the same transformation experiment with the wild-type p53 plasmid were used for in vitro synthesis of the p53 protein.
The same amount of plasmid (100 ng) was used for each experiment. In this range of plasmid concentration, the amount of protein synthesized varies linearly with the amount of plasmid present in the assay (data not shown). This makes it possible to normalize the amount of protein synthesized. Moreover, the oligonucleotide concentration used in the assay corresponds to 1.5 × K (K represents the affinity constant for DNA). This ensures that small changes in the protein concentration will lead to linear changes in the amount of bound DNA.
The DNA-binding activity of different translation mixtures containing wild-type p53 was measured and the data analyzed with and without normalization to the amount of protein synthesized (Figure 1) . The results obtained clearly show that the variability on the measurement of the DNA-binding activity is lower when the data are normalized to the amount of protein. The standard deviation of the normalized values represents 4% of the mean DNA-binding value while it represents 12% for the non-normalized data. The same experiment repeated at a different day gives a deviation of 3% and 17%, respectively. This shows that the comparison of different experiments is more accurate when the DNA-binding activity values are normalized to the amount of protein present in the translation mixture. This was the case when very similar translation mixtures were compared. This effect is even more pronounced when the activity of different mutant proteins is compared (data not shown) because the plasmids used for translation are totally different clones.
In summary, a method that permits a better comparison of the DNA-binding activity of in vitro-synthesized proteins was described. This method allows the researcher to compare in a very short time and with higher accuracy the DNA-binding activity of DNA-binding proteins.
Using a Eukaryotic GST Fusion Vector for Proteins Difficult to Express in E. coli
BioTechniques 23:794-800 (November 1997) The expression and purification of recombinant proteins is an important step in the biochemical analysis and functional characterization of cloned genes. A widely used strategy for protein isolation involves expression of the protein in bacterial cells as a fusion construct with a tagged epitope to enable rapid purification through retention on affinity column matrices (8,9, 12). The expression of mammalian proteins in prokaryotic systems often leads to low-expression yield, insolubility and extensive proteolysis that limit the application of this approach to lowmolecular-weight, stable cytoplasmic proteins.
In the course of the analysis of a zinc ion finger transcription factor, Roaz (16), and the helix-loop-helix (HLH) protein, Olf1/EBF (O/E1) (5,17), we encountered significant difficulties with low-expression yield of the Roaz protein and proteolysis of O/E1 in Escherichia coli . A eukaryotic expression vector, pCMV-GST ( Figure  1A) , was designed to circumvent the limitations imposed by expression in bacteria. The pCMV-GST vector was constructed on the core vector pCIS (C. Gorman, Genentech, South San Francisco), which contains a cytomegalovirus (CMV) promoter, 5 ′ intron, simian virus 40 (SV40) polyadenylation signal and the SV40 origin of replication (15,18). The SV40 origin allows replication of a plasmid to high copy number in HEK293 cells when T antigen is present (6,7). The pCMV-GST vector expresses the desired protein as an N-terminal glutathione Stransferase (GST) fusion (from Schistosoma japonicum) that utilizes an optimal consensus sequence to initiate translation ( Figure 1A) . A convenient multiple cloning site (MCS) that provides Sal I/ Xho I sites (with compatible ends) and Sma I/ Eco RV sites (with blunt ends) permits insertion of fragments in two different reading frames. The vector also contains a protein kinase A (PKA) phosphorylation site for radiolabeling the protein with [ γ -32 P] ATP, a thrombin cleavage site to separate the expression protein from the GST polypeptide, three-frame stop codons at the 3 ′ end and an SV40 polyadenylation signal ( Figure 1B) . A similar eukaryotic GST fusion vector was designed and used as a tool for the study of protein-protein associations invivo (2) .
The levels of expression and proper -
